Biochemistry, Genetics and Molecular Biology
Saccharopolyspora
96%
Carcinogenesis
76%
Homeobox
72%
Hypoxia-Inducible Factors
60%
Gene Expression
51%
TANK-binding Kinase 1
48%
Oxygenase
48%
Deubiquitination
48%
Cancer Cell
45%
Transcription
43%
Metabolic Pathway
39%
Enzyme
36%
Cell Growth
35%
Nitrogen Metabolism
35%
Small Interfering RNA
30%
Von Hippel-Lindau Tumor Suppressor
30%
Hydroxylation
30%
Actinobacteria
30%
Tumor Progression
28%
Chromatin Immunoprecipitation
28%
Gene Expression Profiling
27%
Kinase
26%
Phosphotransferase
26%
Proline
26%
Oxygen Sensing
24%
T Cell
24%
Epigenetics
24%
Ubiquitin
24%
Pyrimidine Biosynthesis
24%
Starch
24%
Peptidase
24%
KLF2
24%
Kinome
24%
Histone H3
24%
Tumor Hypoxia
24%
Chimeric Antigen Receptor
24%
Cell Metabolism
24%
FOXP1
24%
Messenger RNA
24%
Acyltransferase
24%
N-Acetyltransferase
24%
Doublecortin
24%
Zinc Finger Transcription Factor
24%
Citrate Synthase
24%
Single-Domain Antibody
24%
Lipid Droplet
24%
Angiogenesis
24%
Vascularization
24%
Tumor-Associated Macrophage
24%
Diacylglycerol
24%
Keyphrases
Clear Cell Renal Cell Carcinoma (ccRCC)
100%
Homeobox
72%
Kidney Cancer
72%
Zinc Finger
72%
Oncogenic Signaling
48%
Deubiquitination
48%
Tumorigenesis
37%
HIF-2
34%
Von Hippel-Lindau
33%
Triple-negative Breast Cancer
32%
Chromatin Immunoprecipitation (ChIP)
30%
Hypoxia-inducible factor-1α (HIF-1α)
30%
Transcription Factor
29%
Hypoxia
28%
Gene Expression
27%
Oncogenic Drivers
27%
Hydroxylation
27%
Tagged Protein
24%
Doublecortin-like Kinase 1 (DCLK1)
24%
Amylolytic Enzymes
24%
PhoP
24%
Tumor Hypoxia
24%
Epitope
24%
Saccharopolyspora Erythraea
24%
Ubiquitin-specific Peptidase
24%
Histone H3
24%
γ-Butyrobetaine Hydroxylase
24%
IP3R3
24%
Kinome
24%
Nitrogen Regulator GlnR
24%
Pigment Biosynthesis
24%
GlnR
24%
KDM5A
24%
Proline
24%
Small Interfering RNA (siRNA)
24%
Patient-Reported Outcomes Measurement Information System (PROMIS)
24%
Protocol Optimization
24%
Therapeutic Implications
24%
TANK-binding Kinase 1 (TBK1)
24%
USP13
24%
Diacylglycerol O-acyltransferase 1
24%
Protein Signaling
24%
Signaling Axis
24%
Hypoxia-inducible Factor
20%
GltA
20%
H3K4me3
19%
EGLN2
16%
Mammalian Cells
16%
Histone Post-translational Modifications
16%
Putative Drug Targets
16%
Medicine and Dentistry
Triple Negative Breast Cancer
72%
Clear Cell Renal Cell Carcinoma
72%
Zinc Finger Protein
48%
Homeobox
48%
Neoplasm
47%
Gamma Butyrobetaine Dioxygenase
45%
Disease
37%
Cancer
28%
Hypoxia
28%
Hypoxia Inducible Factor
27%
Small Interfering RNA
26%
Transcription Factors
24%
Immunotherapy
24%
Phosphotransferase
24%
Nanobody
24%
Breast Cancer
24%
Tumor Microenvironment
24%
Macrophage
24%
Doublecortin
24%
Therapeutic Modality
24%
Kidney Cancer
24%
Deubiquitination
24%
Tumor Hypoxia
24%
Oxygen Sensing
24%
Signaling Protein
24%
In Vitro
20%
Xenograft
20%
Malignant Neoplasm
19%
Gene Expression Profiling
15%
Homeostasis
12%
Pyrimidine Synthesis
12%
Ubiquitin Protein Ligase E3
12%
Breast Tumor
12%
Clear Cell
12%
Hypoxia Signalling
12%
Cancer Therapy
10%
Combination Therapy
10%
Immunosuppressive Treatment
9%
Immunosuppressive Drug
9%
Breast Cancer Cell Line
9%
Angiogenesis
8%
Metastatic Carcinoma
8%
Cancer Cell
8%
Vasculotropin
8%
Hypoxia Inducible Factor Proline Dioxygenase
8%
Dioxygenase
8%
Pharmaceutical Care
8%
Drug Action
8%
Targeted Therapy
6%
Carcinogenesis
6%
